METHODS INVOLVING THE USE OF CAPG AS A DIAGNOSTIC MARKER AND METHODS FOR THE IDENTIFICATION OF CAPG MODULATORS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS AND RELATED DISEASE STATES - Patent 1368487

(19)

(11)

EP 1 368 487 A1

(12)

(43)	Date of publication:
	10.12.2003 Bulletin 2003/50

(21)	Application number: 02753651.5

(22)	Date of filing: 15.03.2002

(51)	International Patent Classification (IPC)⁷: C12Q 1/00, A61K 39/00

(86)	International application number:
	PCT/US0208/142

(87)	International publication number:
	WO 0207/4982 (26.09.2002 Gazette 2002/39)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

15.03.2001 US 276250 P

(71)	Applicant: Bristol-Myers Squibb Company
	Princeton, NJ 08543-4000 (US)

(72)	Inventor:
	MCATEE, C., Patrick Pennington, NJ 08534 (US)

(74)	Representative: VOSSIUS & PARTNER
	Siebertstrasse 4 81675 München 81675 München (DE)

(54)	METHODS INVOLVING THE USE OF CAPG AS A DIAGNOSTIC MARKER AND METHODS FOR THE IDENTIFICATION OF CAPG MODULATORS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS AND RELATED DISEASE STATES